Biomarkers of vaccine
safety and efficacy
in vulnerable populations
October, 5-6 2023
Co-hosted by the Precision Vaccines Program of Boston Children’s Hospital (BCH; Boston, MA) and Ospedale Pediatrico Bambino Gesù (OPBG; Rome, Italy), the Biomarkers of vaccine safety and efficacy in Vulnerable Population Conference is developed by the IPVC Organizing Committee led by Prof. Ofer Levy of Boston Children’s Hospital and Prof. Paolo Palma of Ospedale Pediatrico Bambino Gesù. This in-person conference will gather experts in vaccinology and immunology from academia, government and industry to provide insight on the conference theme:
Precision Vaccines: Biomarkers of vaccine safety and efficacy in vulnerable populations
Vaccines prevent ~3 million deaths every year and are crucial in combating antimicrobial resistance. Optimizing implementation of existing vaccines could help avert up to 1.5 million additional deaths as well as disabilities resulting from vaccine preventable diseases. Immunologically vulnerable populations (VPs), including pregnant women, term and preterm newborns and young infants, older adults and patients affected by chronic or immunocompromising conditions are frequently under-vaccinated and/or at risk of reduced vaccine efficacy, presenting a major health and economic burden to society. Vaccine development programs mainly focus on healthy populations; therefore, vaccination strategies are often based on data arising from healthy study participants. The goal of the 4th International Precision Vaccines Conference is to discuss and reflect on recent studies of vaccine safety and immunogenicity relevant to vulnerable populations. We welcome abstracts from different disciplines, spanning scientific areas in epidemiology, basic immunology, systems vaccinology, and human in vitro modeling. We encourage submissions focused on the following themes:
- Host-, pathogen- or drug-related mechanisms that can affect responsiveness to vaccines in VPs
- Safety and immunogenicity of existing and novel vaccines for different pathological conditions and age groups, represented by VPs
- Proposed new biomarkers of safety and efficacy to guide effective optimal vaccination of VPs
Parco dei Principi Grand Hotel & Spa
Via G. Frescobaldi, 5 – 00198 Roma, Italy
Paolo Palma, MD, PhD
Ofer Levy, MD, PhD
Stanley Plotkin, MD
Olubukola “Bukky” Idoko, MD, PhD, MSc
Nicola Cotugno MD, PhD
Asimenia Angelidou, MD, PhD
Nicole Lewis, Giulia Neccia, Jennifer Faudella, Mehmet Saluvan
Donato Amodio MD, PhD
Gaby Baldeon Vaca
Nicola Cotugno MD, PhD
Philip Goulder, FRCPCH, DPhil, FMedSci
Prof. Paul Heath
Jessica Lasky-Su DSc, MS
Ofer Levy, M.D., Ph.D.
Prof. Dr. Kirsten Maertens
Paolo Palma, M.D., Ph.D.
Sir Andrew Pollard
Rino Rappuoli, Ph.D.
Prof. Walter Ricciardi
Scott Tebbutt, Ph.D.
Claire Thorne Msc, PhD
Karina Top, MD, MSc, FRCPC
Pierre Van Damme, M.D., Ph.D.
Ivan Zanoni, Ph.D.
last tickets available!
|Attendee on site||€ 150,00||€ 550,00||€ 850,00|
|Virtual*||€ 150,00||€ 250,00||€ 250,00|
Call for Papers
We are excited to announce that we will be partnering with the journal Vaccine for a special themed issue entitled “Precision Vaccines: Biomarkers of vaccine safety & efficacy in vulnerable populations”: www.sciencedirect.com IPVC presenters are encouraged to submit a manuscript for consideration. Please select “VSI: Vaccines for the vulnerable” when submitting your manuscript to this special issue and indicate the actual article type in the cover letter. The submission portal will be open from October 8, 2023 until April 15, 2024
Hotels suggested near the meeting venue
For further information, please get in touch with the hotel.
Sponsorship & Exhibitor Levels & Pricing
|Sponsorship Levels||€ 2.500,00||€ 5.000,00||€ 10.000,00||€ 20.000,00|